Approval · Notice of Compliance 9368 · 2008
DOBUTREX: Notice of Compliance 9368
Issued February 12, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9368
- Date
- February 12, 2008
- Company
- Pharmaceutical Partners Of Canada IncRichmond Hill, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Sympathomimetic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DOBUTREX | 00759538 | Cancelled Post Market |
Medicinal ingredients
- DOBUTAMINE HCL 12.5 MG per ML